A Glimpse into the Future: In 2020, Which Patients Will Undergo TAVI or SAVR?

Overview

Journal Interv Cardiol

Date 2018 Mar 29

PMID 29588730

Citations 2

Authors

Crochan J OSullivan

Peter Wenaweser

Affiliations

Soon will be listed here.

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved into a safe and effective procedure to treat symptomatic patients with severe aortic stenosis (AS), with predictable and reproducible results. Rates of important complications such as vascular complications, strokes and paravalvular leaks are lower than ever, because of improved patient selection, systematic use of multidector computer tomography, increasing operator experience and device iteration. Accumulating data suggest that transfemoral TAVI with newer generation transcatheter heart valves and delivery systems is superior to conventional surgical aortic valve replacement among intermediate- and high-risk patients with severe symptomatic AS with regard to all-cause mortality and stroke. One can anticipate that by 2020, the majority of patients with severe symptomatic AS will undergo TAVI as first line therapy, regardless of surgical risk.

Citing Articles

Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time.

Ammar A, Hassan Rizvi S, Saghir T, Khan N, Akhtar P, Mengal N Cureus. 2020; 12(11):e11497.

PMID: 33354443 PMC: 7744204. DOI: 10.7759/cureus.11497.

Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.

Makikallio T, Jalava M, Husso A, Virtanen M, Laakso T, Ahvenvaara T Ann Med. 2019; 51(3-4):270-279.

PMID: 31112060 PMC: 7880078. DOI: 10.1080/07853890.2019.1614657.

References

Wenaweser P, Buellesfeld L, Gerckens U, Grube E . Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv. 2007; 70(5):760-4. DOI: 10.1002/ccd.21300. View

Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra S, Mavromatis K . Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014; 7(8):898-904. DOI: 10.1016/j.jcin.2014.04.005. View

Andersen H, Knudsen L, M Hasenkam J . Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992; 13(5):704-8. DOI: 10.1093/oxfordjournals.eurheartj.a060238. View

Genereux P, Stone G, OGara P, Marquis-Gravel G, Redfors B, Giustino G . Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2016; 67(19):2263-2288. DOI: 10.1016/j.jacc.2016.02.057. View

Dvir D, Webb J, Bleiziffer S, Pasic M, Waksman R, Kodali S . Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014; 312(2):162-70. DOI: 10.1001/jama.2014.7246. View

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-98. DOI: 10.1056/NEJMoa1103510. View

OSullivan C, Windecker S . Implications of bicuspid aortic valves for transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013; 6(3):204-6. DOI: 10.1161/CIRCINTERVENTIONS.113.000461. View

Khalique O, Kodali S, Paradis J, Nazif T, Williams M, Einstein A . Aortic annular sizing using a novel 3-dimensional echocardiographic method: use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2013; 7(1):155-63. DOI: 10.1161/CIRCIMAGING.113.001153. View

10.

Wenaweser P, Praz F, Stortecky S . Transcatheter aortic valve implantation today and tomorrow. Swiss Med Wkly. 2016; 146:w14299. DOI: 10.4414/smw.2016.14299. View

11.

Roy D, Schaefer U, Guetta V, Hildick-Smith D, Mollmann H, Dumonteil N . Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013; 61(15):1577-84. DOI: 10.1016/j.jacc.2013.01.018. View

12.

Siontis G, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G . Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016; 37(47):3503-3512. DOI: 10.1093/eurheartj/ehw225. View

13.

Willson A, Webb J, LaBounty T, Achenbach S, Moss R, Wheeler M . 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012; 59(14):1287-94. DOI: 10.1016/j.jacc.2011.12.015. View

14.

Abdel-Wahab M, Neumann F, Mehilli J, Frerker C, Richardt D, Landt M . 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial. J Am Coll Cardiol. 2015; 66(7):791-800. DOI: 10.1016/j.jacc.2015.06.026. View

15.

Nombela-Franco L, Barbosa Ribeiro H, Urena M, Allende R, Amat-Santos I, DeLarochelliere R . Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014; 63(24):2643-58. DOI: 10.1016/j.jacc.2014.02.573. View

16.

Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R . Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013; 112(2):272-9. DOI: 10.1016/j.amjcard.2013.03.024. View

17.

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F . Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106(24):3006-8. DOI: 10.1161/01.cir.0000047200.36165.b8. View

18.

Patsalis P, Al-Rashid F, Neumann T, Plicht B, Hildebrandt H, Wendt D . Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. JACC Cardiovasc Interv. 2013; 6(9):965-71. DOI: 10.1016/j.jcin.2013.05.006. View

19.

Lindman B, Maniar H, Jaber W, Lerakis S, Mack M, Suri R . Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circ Cardiovasc Interv. 2015; 8(4). PMC: 4438083. DOI: 10.1161/CIRCINTERVENTIONS.114.002073. View

20.

Motloch L, Rottlaender D, Reda S, Larbig R, Bruns M, Muller-Ehmsen J . Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2011; 101(1):45-53. DOI: 10.1007/s00392-011-0362-8. View